US Stock MarketDetailed Quotes

Camp4 Therapeutics (CAMP)

Watchlist
  • 4.500
  • 0.0000.00%
Close May 13 16:00 ET
233.67MMarket Cap-1.91P/E (TTM)

Camp4 Therapeutics (CAMP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
23.13%-10.98M
35.14%-29.55M
155.75%6.29M
-15.72%-11.22M
23.03%-10.34M
-28.21%-14.29M
-3.19%-45.56M
4.20%-11.29M
-47.89%-9.69M
-13.44M
Net income from continuing operations
-47.44%-18.33M
-55.25%-80.4M
-203.37%-40.28M
-11.98%-15.1M
-0.09%-12.59M
0.15%-12.43M
-5.07%-51.79M
-2.22%-13.28M
-15.30%-13.48M
---12.58M
Operating gains losses
--6.19M
--30.09M
--28.22M
----
----
----
----
----
----
----
Depreciation and amortization
23.52%520K
-3.36%1.64M
-11.00%372K
-0.48%416K
1.42%430K
-3.44%421K
1.07%1.7M
-3.91%418K
-2.79%418K
--424K
Other non cash items
-94.03%35K
-11.41%1.62M
-65.97%163K
4.48%490K
-15.42%384K
36.28%586K
0.66%1.83M
6.92%479K
16.38%469K
--454K
Change In working capital
76.75%-865K
1,077.31%13.01M
5,512.79%16.67M
-128.15%-369K
116.94%428K
-800.97%-3.72M
-4.89%-1.33M
195.19%297K
-63.44%1.31M
---2.53M
-Change in prepaid assets
14,014.29%974K
-24.89%-888K
-111.68%-779K
-306.40%-419K
-51.38%317K
99.42%-7K
-69.29%-711K
-322.99%-368K
-76.83%203K
--652K
-Change in payables and accrued expense
70.24%-777K
-113.13%-223K
-25.79%731K
-54.67%816K
133.39%841K
-282.21%-2.61M
235.81%1.7M
139.08%985K
201.00%1.8M
---2.52M
-Change in other working capital
3.72%-1.06M
708.84%14.12M
5,324.38%16.72M
-10.69%-766K
-10.77%-730K
-70.22%-1.1M
-676.87%-2.32M
49.76%-320K
-132.77%-692K
---659K
Cash from discontinued investing activities
Operating cash flow
23.13%-10.98M
35.14%-29.55M
155.75%6.29M
-15.72%-11.22M
23.03%-10.34M
-28.21%-14.29M
-3.19%-45.56M
4.20%-11.29M
-47.89%-9.69M
---13.44M
Investing cash flow
Cash flow from continuing investing activities
0
44.90%-243K
0
36K
0
-1,760.00%-279K
34.96%-441K
-8.23%-263K
0
-163K
Net PPE purchase and sale
--0
44.90%-243K
--0
--36K
--0
-1,760.00%-279K
34.96%-441K
-8.23%-263K
--0
---163K
Cash from discontinued investing activities
Investing cash flow
--0
44.90%-243K
--0
--36K
--0
-1,760.00%-279K
34.96%-441K
-8.23%-263K
--0
---163K
Financing cash flow
Cash flow from continuing financing activities
137.75%57K
5.90%75.89M
-60.88%28.59M
12,375.65%47.38M
108.87%72K
25.25%-151K
23,707.97%71.66M
116,071.43%73.06M
-90.15%-386K
-812K
Net issuance payments of debt
--0
69.51%-111K
81.25%-18K
84.44%-14K
51.69%-43K
59.55%-36K
-13.04%-364K
20.66%-96K
-1.12%-90K
---89K
Net common stock issuance
----
-24.67%57.52M
-67.32%24.95M
1,628,200.00%32.56M
--0
--0
--76.35M
636,375.00%76.35M
-300.00%-2K
--0
Proceeds from stock option exercised by employees
--57K
3,131.86%3.65M
4,461.25%3.65M
----
----
--0
-38.92%113K
--80K
----
----
Net other financing activities
----
434.08%14.83M
--0
----
----
0.00%-115K
-1,113.70%-4.44M
-2,747.83%-3.28M
-184.35%-327K
---723K
Cash from discontinued financing activities
Financing cash flow
137.75%57K
5.90%75.89M
-60.88%28.59M
12,375.65%47.38M
108.87%72K
25.25%-151K
23,707.97%71.66M
116,071.43%73.06M
-90.15%-386K
---812K
Net cash flow
Beginning cash position
70.20%111.76M
64.14%65.66M
1,751.61%76.88M
185.83%40.68M
77.86%50.95M
64.14%65.66M
-52.68%40M
-92.03%4.15M
-75.90%14.23M
--28.64M
Current changes in cash
25.77%-10.92M
79.64%46.09M
-43.30%34.88M
459.19%36.2M
28.74%-10.27M
-29.54%-14.72M
157.62%25.66M
608.82%61.51M
-44.73%-10.08M
---14.41M
End cash Position
97.92%100.83M
70.20%111.76M
70.20%111.76M
1,751.61%76.88M
185.83%40.68M
77.86%50.95M
64.14%65.66M
64.14%65.66M
-92.03%4.15M
--14.23M
Free cash flow
24.61%-10.98M
35.15%-29.83M
154.48%6.29M
-15.72%-11.22M
23.95%-10.34M
-30.53%-14.57M
-2.61%-46M
3.95%-11.55M
-43.37%-9.69M
---13.6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 23.13%-10.98M35.14%-29.55M155.75%6.29M-15.72%-11.22M23.03%-10.34M-28.21%-14.29M-3.19%-45.56M4.20%-11.29M-47.89%-9.69M-13.44M
Net income from continuing operations -47.44%-18.33M-55.25%-80.4M-203.37%-40.28M-11.98%-15.1M-0.09%-12.59M0.15%-12.43M-5.07%-51.79M-2.22%-13.28M-15.30%-13.48M---12.58M
Operating gains losses --6.19M--30.09M--28.22M----------------------------
Depreciation and amortization 23.52%520K-3.36%1.64M-11.00%372K-0.48%416K1.42%430K-3.44%421K1.07%1.7M-3.91%418K-2.79%418K--424K
Other non cash items -94.03%35K-11.41%1.62M-65.97%163K4.48%490K-15.42%384K36.28%586K0.66%1.83M6.92%479K16.38%469K--454K
Change In working capital 76.75%-865K1,077.31%13.01M5,512.79%16.67M-128.15%-369K116.94%428K-800.97%-3.72M-4.89%-1.33M195.19%297K-63.44%1.31M---2.53M
-Change in prepaid assets 14,014.29%974K-24.89%-888K-111.68%-779K-306.40%-419K-51.38%317K99.42%-7K-69.29%-711K-322.99%-368K-76.83%203K--652K
-Change in payables and accrued expense 70.24%-777K-113.13%-223K-25.79%731K-54.67%816K133.39%841K-282.21%-2.61M235.81%1.7M139.08%985K201.00%1.8M---2.52M
-Change in other working capital 3.72%-1.06M708.84%14.12M5,324.38%16.72M-10.69%-766K-10.77%-730K-70.22%-1.1M-676.87%-2.32M49.76%-320K-132.77%-692K---659K
Cash from discontinued investing activities
Operating cash flow 23.13%-10.98M35.14%-29.55M155.75%6.29M-15.72%-11.22M23.03%-10.34M-28.21%-14.29M-3.19%-45.56M4.20%-11.29M-47.89%-9.69M---13.44M
Investing cash flow
Cash flow from continuing investing activities 044.90%-243K036K0-1,760.00%-279K34.96%-441K-8.23%-263K0-163K
Net PPE purchase and sale --044.90%-243K--0--36K--0-1,760.00%-279K34.96%-441K-8.23%-263K--0---163K
Cash from discontinued investing activities
Investing cash flow --044.90%-243K--0--36K--0-1,760.00%-279K34.96%-441K-8.23%-263K--0---163K
Financing cash flow
Cash flow from continuing financing activities 137.75%57K5.90%75.89M-60.88%28.59M12,375.65%47.38M108.87%72K25.25%-151K23,707.97%71.66M116,071.43%73.06M-90.15%-386K-812K
Net issuance payments of debt --069.51%-111K81.25%-18K84.44%-14K51.69%-43K59.55%-36K-13.04%-364K20.66%-96K-1.12%-90K---89K
Net common stock issuance -----24.67%57.52M-67.32%24.95M1,628,200.00%32.56M--0--0--76.35M636,375.00%76.35M-300.00%-2K--0
Proceeds from stock option exercised by employees --57K3,131.86%3.65M4,461.25%3.65M----------0-38.92%113K--80K--------
Net other financing activities ----434.08%14.83M--0--------0.00%-115K-1,113.70%-4.44M-2,747.83%-3.28M-184.35%-327K---723K
Cash from discontinued financing activities
Financing cash flow 137.75%57K5.90%75.89M-60.88%28.59M12,375.65%47.38M108.87%72K25.25%-151K23,707.97%71.66M116,071.43%73.06M-90.15%-386K---812K
Net cash flow
Beginning cash position 70.20%111.76M64.14%65.66M1,751.61%76.88M185.83%40.68M77.86%50.95M64.14%65.66M-52.68%40M-92.03%4.15M-75.90%14.23M--28.64M
Current changes in cash 25.77%-10.92M79.64%46.09M-43.30%34.88M459.19%36.2M28.74%-10.27M-29.54%-14.72M157.62%25.66M608.82%61.51M-44.73%-10.08M---14.41M
End cash Position 97.92%100.83M70.20%111.76M70.20%111.76M1,751.61%76.88M185.83%40.68M77.86%50.95M64.14%65.66M64.14%65.66M-92.03%4.15M--14.23M
Free cash flow 24.61%-10.98M35.15%-29.83M154.48%6.29M-15.72%-11.22M23.95%-10.34M-30.53%-14.57M-2.61%-46M3.95%-11.55M-43.37%-9.69M---13.6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More